This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...
Q4 2025 earnings call highlights: 2026 revenue outlook, Bako/StrataDx deals, AI pathology gains, and customer-loss risks—read now.
Ancient linkups may have happened more frequently between female humans and male Neanderthals, according to an new genetic ...
Ancient linkups may have happened more frequently between female humans and male Neanderthals, according to an new genetic ...
StockStory.org on MSN
Myriad Genetics's (NASDAQ:MYGN) Q4 CY2025 sales top estimates, stock jumps 22%
Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported in Q4 CY2025, but sales were flat year on year at $209.8 million. The company expects the full year’s revenue to be around $870 million, ...
BOSTON and ROLLE, Switzerland, March 3, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the fourth quarter ...
Human biologist Gary Brecka of The Ultimate Human has been lauded as a “longevity guru” by celebrities, clients, and ...
Burn Slim announces an official consumer safety warning after counterfeit and tainted versions of its natural GLP-1 mimetic weight loss formula were identified on unauthorized retail platforms and ...
Noah's Ark theory ignites explosive debate over the origins of the eight human blood types, with many people saying: 'This isn't just possible … it's true.' ...
Feb. 21, 2026 Location: at the farm near Kimball, MN Auctioneer: Lynn Weishaar, Ty Thompson, Dace Harper Sales Manager: Rance Long Averages:340 Angus Bulls – $15,08942 SimAngus ...
Massive Swedish study of over two million people reveals that genetic risk for mental illness often points toward ...
Zacks Investment Research on MSN
Exelixis (EXEL) down 2.8% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Exelixis (EXEL). Shares have lost about 2.8% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results